Hereditary angioedema attacks resolve faster and are shorter after early icatibant treatment.

BACKGROUND: Attacks of hereditary angioedema (HAE) are unpredictable and, if affecting the upper airway, can be lethal. Icatibant is used for physician- or patient self-administered symptomatic treatment of HAE attacks in adults. Its mode of action includes disruption of the bradykinin pathway via b...

Full description

Bibliographic Details
Main Authors: Marcus Maurer, Werner Aberer, Laurence Bouillet, Teresa Caballero, Vincent Fabien, Gisèle Kanny, Allen Kaplan, Hilary Longhurst, Andrea Zanichelli, I O S Investigators
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3563637?pdf=render